NZ sharemarket falls 1.2% despite F&P's record result

NZ sharemarket falls 1.2% despite F&P's record result
The local market followed Wall St, (Image: Getty)
Graham Skellern
Record half-year revenue from heavyweight Fisher and Paykel Healthcare couldn’t stop the New Zealand sharemarket falling more than 1%, while Ryman Healthcare again disappointed investors.Following a down day on Wall Street, the S&P/NZX 50 Index fell at the opening and traded on a reasonably flat line to close at 13,053.56 points, down 159.36 points or 1.21%. There were 33.83 million share transactions worth $135.94m.'Writing is on the wall'Market leader Fisher and Paykel Healthcare declined 57c to $37.85 after reporting r...

More Markets

No encore: Potentia exits Vista stake
Markets

No encore: Potentia exits Vista stake

Despite board snub, Australian investor is still keen on NZ software businesses.

NZ banking capital adequacy proposals may face choppy seas
Economy

NZ banking capital adequacy proposals may face choppy seas

Plans to reset NZ banks’ capital adequacy rules appear to be garnering support.

Vital buyout deadline looms, ACC yet to make move
Markets

Vital buyout deadline looms, ACC yet to make move

One large shareholder has said he intends to accept, but has yet to officially do so.